Dupixent 300 MG/2 ML pen 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26F6T4T
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $16,915
Award facts
- Contract value 100% obligated
- $16,914.95 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $16,914.95 for Dupixent 300 mg/2 ml pen (2 ml) with a completion date of December 2, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. The order will be fulfilled from the vendor's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999.999 billion and extends through December 2026, serving as a comprehensive global pharmaceutical support vehicle for military healthcare programs.
Dupixent (dupilumab) is a biologic medication used to treat conditions including moderate-to-severe atopic dermatitis, asthma, and chronic rhinosinusitis with nasal polyps. AmerisourceBergen, a major pharmaceutical distributor and critical federal medical procurement vendor, maintains an extensive portfolio of medical product deliveries to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's DLA Troop Support contract encompasses a broad range of pharmaceutical products including specialty medications, brand-name and generic drugs, vaccines, and medical supplies across multiple therapeutic domains, positioning it as a key supplier for Department of Defense medical procurement needs.
Quick answers
Who was awarded contract SPE2DR26F6T4T?
SPE2DR26F6T4T was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 1, 2025.
How much is contract SPE2DR26F6T4T worth?
The government has obligated $16,915 on SPE2DR26F6T4T.
Is contract SPE2DR26F6T4T an order under another contract?
Yes. SPE2DR26F6T4T is a delivery order under SPE2DR25D3013, an indefinite delivery contract.
Was contract SPE2DR26F6T4T competed?
The extent of competition for SPE2DR26F6T4T was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award